103 results on '"Krueger, James G."'
Search Results
2. Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa
3. Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa
4. Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1
5. Genomic Profiling of the Overlap Phenotype between Psoriasis and Atopic Dermatitis
6. Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis
7. Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis
8. Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis
9. Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets
10. Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients
11. In-Depth Analysis of the Hidradenitis Suppurativa Serum Proteome Identifies Distinct Inflammatory Subtypes
12. Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week
13. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation
14. Quantifying the natural variation in lesion counts over time in untreated hidradenitis suppurativa: Implications for outcome measures and trial design
15. A Preliminary 18F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic Dermatitis
16. Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis
17. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis
18. Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy
19. Early Quantification of Systemic Inflammatory Proteins Predicts Long-Term Treatment Response to Tofacitinib and Etanercept
20. Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis
21. Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood
22. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
23. Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis
24. IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis
25. The skin as an immune organ: Tolerance versus effector responses and applications to food allergy and hypersensitivity reactions
26. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis
27. Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab
28. Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases
29. Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature
30. Atopic dermatitis endotypes and implications for targeted therapeutics
31. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
32. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
33. The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in Blood
34. Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment
35. TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study
36. An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease
37. Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling
38. Shrinking the Psoriasis Assessment Gap: Early Gene-Expression Profiling Accurately Predicts Response to Long-Term Treatment
39. An IL-17–dominant immune profile is shared across the major orphan forms of ichthyosis
40. Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
41. Lipoprotein Metabolism and Inflammation in Patients With Psoriasis
42. A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis
43. The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases
44. Petrolatum: Barrier repair and antimicrobial responses underlying this “inert” moisturizer
45. Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis
46. A systematic review and critical appraisal of pharmacological treatments for pediatric hidradenitis suppurativa
47. Staphylococcus Aureus and Streptococcus Pyogenes Induce Psoriasis-Related Transcriptomes Augmented by IL-17A and TNF-α
48. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
49. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
50. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)+ TH2/TH1 cell imbalance, whereas adults acquire CLA+ TH22/TC22 cell subsets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.